Head & Neck Surgery, Tata Memorial Hospital, Mumbai, India.
Head & Neck Surgery, Department of Head and Neck Surgery, Narayana Superspeciality Hospital, Kolkata, India.
Eur J Surg Oncol. 2019 Jun;45(6):1033-1038. doi: 10.1016/j.ejso.2019.01.224. Epub 2019 Feb 5.
Surgical margin is one of the most important prognostic factors in oral cavity squamous cell carcinoma. There have been studies which refute the standard practice of considering 5 mm (mm) margin as free. Therefore we aimed to evaluate the impact of each mm of margin on the local recurrence free survival (LRFS) and to obtain a cut-off value which would impact the survival the most.
This was a retrospective study of 602 treatment naïve patients of buccoalveolar complex cancer. ROC curve was plotted for each millimetre of margin to derive the cut-off margin for maximum LRFS. Multivariate analysis was done for the margin groups to calculate the margin beyond which no significant improvement on LRFS was achieved. Early and advanced tumors were also evaluated separately.
A cut off margin of 5.5 mm was achieved on ROC for early (T1-T2) tumors and 6.5 mm cut off was achieved for advanced (T3-T4) tumors. Based on these cut off different margin groups were made. The cohort was grouped into positive margin, 1-5.5 mm, 5.6-7 mm and > 7 mm. Hazard ratio for patients with 1-5.5 mm and positive margin was 1.886 (95%CI, 1.15 to 3.09) and 5.58 (95%CI, 1.75 to 17.78) respectively. HR for margin 5.5 mm to 7 mm was 1.15 (95% CI, 1.15 to 2.06). There was no statistically significant difference in survival between margin groups of 5.6-7 mm and > 7 mm (p < 0.589) for both early and advanced tumors.
Minimum surgical margins of 5.5 mm in the final histopathology should be aimed for in the bucco-alveolar carcinomas. There was significant improvement in LRFS with increasing margins upto 7 mm. Taking margins beyond 7 mm does not improve LRFS.
手术切缘是口腔鳞状细胞癌最重要的预后因素之一。有研究否定了将 5 毫米(mm)作为无切缘的标准做法。因此,我们旨在评估切缘每增加 1 毫米(mm)对局部无复发生存(LRFS)的影响,并得出对生存影响最大的切点值。
这是一项对 602 例初治颊牙槽复合体癌患者的回顾性研究。为获得最大 LRFS 的切点切缘,为每毫米(mm)的切缘绘制 ROC 曲线。对切缘组进行多变量分析,以计算 LRFS 无显著改善的切缘。还分别评估了早期和晚期肿瘤。
ROC 分析得出,早期(T1-T2)肿瘤的切点切缘为 5.5mm,晚期(T3-T4)肿瘤的切点切缘为 6.5mm。基于这些切点值,将不同的切缘组分组。该队列分为阳性切缘、1-5.5mm、5.6-7mm 和>7mm。1-5.5mm 和阳性切缘的患者危险比分别为 1.886(95%CI,1.15-3.09)和 5.58(95%CI,1.75-17.78)。5.5mm-7mm 切缘的 HR 为 1.15(95%CI,1.15-2.06)。对于早期和晚期肿瘤,5.6-7mm 和>7mm 切缘组之间的生存率无统计学差异(p>0.589)。
在颊牙槽癌中,最终病理的最小手术切缘应为 5.5mm。LRFS 随着切缘增加至 7mm 而显著改善。超过 7mm 的切缘不会改善 LRFS。